Breast | Breast-DCIS | Colon | Endometrium | Esophagus | GIST | Kidney | Lung | Prostate | Skin | Stomach | Thyroid

Prostate Biopsies

IHC table: TUO Mucinous Carcinomas
IHC table: Carcinomas of Unknown Origin
IHC table: Renal Carcinomas
IHC table: Germ Cell Tumors
Fields to view based on lens diameter
Molecular and IHC Tests

Breast Carcinoma Worksheet

Specimen Data:
Procedure







Specimen Laterality


Specimen Metrics

Specimen Integrity


Tumor/Specimen Location


Tumor Data:
Carcinoma Type:














Skin involvement






Peau d'orange (involving less than 1/3 of breast skin)
Inflammatory carcinoma present, clinically (at least 1/3 of skin)
Tumor Size (invasive component):

Skeletal muscle involvement



Angiolymphatic Invasion

Tumor Grading

Tubules


Nuclei


Mitoses


Overall grade:


In Situ Carcinoma:
Presence of in situ carcinoma




Architectural patterns





Nuclear grade





Margins:
MarginInvasive TumorIn Situ Tumor














MarginInvasive TumorIn Situ Tumor














MarginInvasive TumorIn Situ Tumor















Staging
Lymph Node Status

SiteSampledPositive
(>2.0mm)
MicMets
(≤2.0mm,
>0.2mm)
ITCs
(≤0.2mm)
Sentinel lymph nodes
Axillary/intramammary nodes
Non-regional lymph nodes
Metastasis Status

Miscellaneous
Treatment Effect




Modifiers






Receptor Studies
ER-IHC
ER-IHC:
Result:
Strength:
Prior:
PR-IHC
PR-IHC:
Result:
Strength:
Prior:
Her2-IHC
Her2-IHC:
Result:
Prior:
Her2-FISH
Her2-FISH:
Result:
Prior:
Other Findings











Comments











Free-text Comments





Final Report